Lynozyfic Injection, Solution, Concentrate
Product Images NDC 61755-054

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lynozyfic (NDC 61755-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Regeneron Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mg / 2.5 mL Vial Carton)

This is a description of a medication called LYNOSLIC. It is an injection solution to be used for intravenous infusion after dilution. The medication is available in a single-dose vial containing 5mg. The prescribing information and medication guide can be accessed by scanning a QR code or visiting www.LYNOZYFIC.com. The recommended dosage and instructions for use are outlined in the text. The medication should be administered as directed, and any unused portion should be discarded. Additionally, a medication guide is provided that should be dispensed to each patient along with the medication.*

FDA Label Image

Principal Display Panel (200 mg / 10 mL Vial Carton)

The text provides important information about a medication called "LYNOZYFIC" which is a single-dose prescription injection containing 200 mg in a 10 mL vial. It is intended for intravenous infusion after dilution and unused portions should be discarded. The medication comes with a Medication Guide to be dispensed to each patient. For further details, scanning the QR code or visiting www.LYNOZYFIC.com is recommended.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.